Keytru­da gets ac­cel­er­at­ed OK in HER2-pos­i­tive gas­tric can­cer; Twin­Strand gets $50M to hunt for 'nee­dles in a haystack'

King Keytru­da keeps rack­ing up ap­provals, earn­ing a new ac­cel­er­at­ed OK from the FDA on Wednes­day.

Reg­u­la­tors hand­ed down the ap­proval …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.